IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development

IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development

Bioengineering & Translational Medicine

Saved in:

Bibliographic Details
Main Authors:	Blasiak, Agata, Lim, Jhin Jieh, Seah, Shirley Gek Kheng, Kee, Theodore, Remus, Alexandria, Chye, De Hoe, Wong, Pui San, Hooi, Lissa, Truong, Anh TL, Le, Nguyen, Chan, Conrad EZ, Desai, Rishi, Ding, Xianting, Hanson, Brendon J, Chow, Edward Kai-Hua, Ho, Dean
Other Authors:	LIFE SCIENCES INSTITUTE
Format:	Article
Published:	Wiley 2023
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/239364
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development
by: Blasiak, Agata, et al.
Published: (2022)

IDentif.AI-Omicron: Harnessing an AI-Derived and Disease-Agnostic Platform to Pinpoint Combinatorial Therapies for Clinically Actionable Anti-SARS-CoV-2 Intervention
by: Blasiak, Agata, et al.
Published: (2022)

The IDentif.AI-x pandemic readiness platform: rapid prioritization of optimized COVID-19 combination therapy regimens
by: Blasiak, Agata, et al.
Published: (2023)

The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens.
by: Blasiak, Agata, et al.
Published: (2022)

Overcoming Pilotitis in Digital Medicine at the Intersection of Data, Clinical Evidence, and Adoption
by: Egermark, Mathias, et al.
Published: (2023)

THERAPEUTIC COMBINATION OPTIMIZATION FOR HEPATOCELLULAR CARCINOMA
by: LIM JHIN JIEH
Published: (2021)

Characteristics of Mobile Health Platforms for Depression and Anxiety: Content Analysis Through a Systematic Review of the Literature and Systematic Search of Two App Stores
by: Leong, Qiao Ying, et al.
Published: (2023)

ELT in the Time of the Coronavirus 2020: Part 2
by: Wong Jock Onn
Published: (2020)

Rapid electrochemical detection of coronavirus SARS-CoV-2
by: Thanyarat Chaibun, et al.
Published: (2022)

EPIGENETICS OF HEPATOCELLULAR CARCINOMA.
by: Toh, Tan Boon, et al.
Published: (2019)

Effects of acute severe acute respiratory syndrome coronavirus 2 infection on male hormone profile, ACE2 and TMPRSS2 expression, and potential for transmission of severe acute respiratory syndrome coronavirus 2 in semen of Asian men
by: Huang, Z, et al.
Published: (2022)

Safety and potential efficacy of cyclooxygenase-2 inhibitors in coronavirus disease 2019
by: Ong, S.W.X., et al.
Published: (2021)

Phylogenetic analysis of feline infectious peritonitis virus, feline enteric coronavirus, and severe acute respiratory syndrome coronavirus 2 of cats in Surabaya, Indonesia
by: Eduardus Bimo Aksono Herupradoto, et al.
Published: (2023)

Methodology in core outcome set (COS) development: the impact of patient interviews and using a 5-point versus a 9-point Delphi rating scale on core outcome selection in a COS development study
by: Remus, Alexandria, et al.
Published: (2023)

Evaluation of different platforms for the detection of anti-SARS coronavirus-2 antibodies, Thailand
by: Hatairat Lerdsamran, et al.
Published: (2022)

Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors
by: Lim, Jhin Jieh, et al.
Published: (2023)

Coronavirus tourism: Charming voyagers in time of novel coronavirus
by: Dwi Pratiwi Wulandari, et al.
Published: (2020)

Dismantling myths on the airborne transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
by: Tang, JW, et al.
Published: (2021)

Understanding bat SARS-like coronaviruses for the preparation of future coronavirus outbreaks Implications for coronavirus vaccine development
by: Ng, Oi-Wing, et al.
Published: (2022)

Role of Asymptomatic Children in Community Severe Acute Respiratory Syndrome Coronavirus 2 Transmission
by: Lu, Liangjian, et al.
Published: (2021)

Dynamics of Different Classes and Subclasses of Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants after Coronavirus Disease 2019 and CoronaVac Vaccination in Thailand
by: Poolchanuan P.
Published: (2023)

Identification of the murine coronavirus MP1 cleavage site recognized by papain-like proteinase 2
by: Kanjanahaluethai A., et al.
Published: (2014)

Molecular characterisation and tracking of severe acute respiratory syndrome coronavirus 2 in Thailand, 2020–2022
by: Puenpa J.
Published: (2023)

New-onset type 1 diabetes and severe acute respiratory syndrome coronavirus 2 infection
by: Anindya, Roy, et al.
Published: (2023)

COVID-19, Coronavirus, Wuhan Virus, or China Virus? Understanding how to “Do No Harm" when naming an infectious disease
by: MASTERS-WAAGE, Theodore C., et al.
Published: (2020)

Understanding the user: Patients' perception, needs, and concerns of health apps for chronic constipation
by: Lee, V Vien, et al.
Published: (2022)

Coronavirus COVID-19
Published: (2020)

Coronavirus sequence analysis
by: Lee, Kenneth
Published: (2024)

Angiotensin converting enzyme 2 at the interface between renin-angiotensin system inhibition and coronavirus disease 2019
by: Natthaphat Siri-Angkul, et al.
Published: (2020)

Extrapulmonary manifestations and complications of severe acute respiratory syndrome coronavirus 2 infection: a systematic review.
by: Cho, Jiacai, et al.
Published: (2021)

Early seasonal coronavirus seroconversion did not produce cross-protective SARS-CoV-2 antibodies.
by: Wong, Lydia Su Yin, et al.
Published: (2022)

The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus - evolved or yet to evolve
by: Budhraja, Anshul, et al.
Published: (2021)

Experimental and natural infections of severe acute respiratory syndrome-related coronavirus 2 in pets and wild and farm animals
by: Gondo Mastutik, Gondo, et al.

Prolonged inflammation in patients hospitalized for coronavirus disease 2019 (COVID-19) resolves 2 years after infection
by: Fong, Siew-Wai, et al.
Published: (2023)

The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus – evolved or yet to evolve
by: Budhraja, Anshul, et al.
Published: (2022)

EARLY CHALLENGES IN ISOLATION AND DE-ISOLATION OF CHILDREN DURING THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 PANDEMIC
by: Chan, Si Min, et al.
Published: (2021)

Discovery of Broad-Spectrum Repurposed Drug Combinations Against Carbapenem-Resistant <i>Enterobacteriaceae</i> (CRE) Through Artificial Intelligence (AI)-Driven Platform
by: Li, Ming, et al.
Published: (2024)

Coronavirus Papain-like Peptidases
by: Kiira Ratia, et al.
Published: (2018)

Coronavirus Papain-like Peptidases
by: Ratia K., et al.
Published: (2014)

Coronavirus Papain-like Peptidases
by: Kiira Ratia, et al.
Published: (2018)